| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,126
|
-
|
-
|
-
| | Cost of Revenue | 55 |
-
|
-
|
-
| | |
Gross Profit
|
1,071
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 8,355 | 9,121 | 6,951 | 8,959 |
|
Selling General and Administrative | 11,143 | 10,164 | 7,763 | 11,333 |
|
Non Recurring |
-
|
-
|
-
| 29,108 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(18,427)
|
(19,285)
|
(14,714)
|
(49,400)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,141) | 576 | (489) | (795) |
|
Earnings Before Interest And Taxes | (19,568) | (18,709) | (15,203) | (50,195) |
|
Interest Expense | 48 | 5 | 43 | 3 |
|
Income Before Tax | (19,616) | (18,714) | (15,246) | (50,198) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest | 232 | 113 | 57 | 60 |
|
|
|
Net Income From Continuing Ops | (19,384) | (18,601) | (15,189) | (50,138) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(19,384)
|
(18,601)
|
(15,189)
|
(50,138)
| | Preferred Stock And Other Adjustments |
-
| (429) | (5,014) | (8,458) | | |
Net Income Applicable To Common Shares
|
(19,384)
|
(19,030)
|
(20,203)
|
(58,596)
|
|
0.02(1.63%) 11:21AM EDT - Nasdaq Real Time Price